RPI Blog Pharmaceutical Outsourcing: Reimagining the Patient Experience in an Evolving Clinical Trial Regulatory Landscape

"Patient centricity" has long been a guiding principle of clinical trial design and conduct, and it has become even more critical in the COVID era as trial sponsors and regulatory authorities have had to adapt to a continually shifting landscape. Pandemic-related restrictions have prompted substantial changes in how clinical trials are developed and implemented, requiring sponsors to comply with new guidance and processes designed to promote speed and efficiency while remaining mindful of patient safety. The U.S. Food and DrugRead moreThe post Pharmaceutical Outsourcing: Reimagining the Patient Experience in an Evolving Clinical Trial Regulatory Landscape appeared first on Regulatory Professionals.